In this study, we provide the first characterization of an eRNA, Fincor, induced by pharmacological activation of FXR and show that Fincor has a beneficial role in reducing liver fibrosis and inflammation in dietary NASH mice. Here, NR1H4 is linked to metabolic dysfunction-associated steatohepatitis.